Archive - March 2022
Deltacron Confirmed, Could This Impact The End Of The Pandemic?
Lynparza Approved in the US as Adjuvant Treatment for Patients with Germline BRCA-Mutated HER2-Negative High-Risk Early Breast Cancer
AbbVie shares positive phase 3 results for migraine drug Qulipta
US bankruptcy judge approves Purdue Pharma’s $6bn opioid settlement plan
Abivax reports promising rheumatoid arthritis results
Waiting times for cancer referrals highest on record
CDC, TSA Extend Mask Mandate On Public Transportation
98% Of US Population Can Ditch Masks As COVID Eases: CDC